Psoriatic arthritis and the spectrum of syndromes related to the SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome

Current Opinion in Rheumatology

Volumn 11, Issue 4, 1999, Pages 251-256

  Winchester, Robert ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ACNE; ALLELE; ARTICLE; CELL INTERACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ETHNIC GROUP; HELPER CELL; HUMAN; HYPEROSTOSIS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PUSTULOSIS; SPONDYLOARTHROPATHY; SUPPRESSOR CELL; SYNDROME; SYNOVITIS;

ACQUIRED HYPEROSTOSIS SYNDROME; ARTHRITIS, PSORIATIC; HIV INFECTIONS; HLA-B27 ANTIGEN; HUMANS;

EID: 0032854214     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199907000-00005     Document Type: Article

References (35)

1. 1 Salvarani C, Olivieri I, Cantini F, Macchioni L, Boiardi L: Psoriatic arthritis. Curr Opin Rheumatol 1998, 10:299-305.
2. 2 Rothschild BM, Pingitore C, Eaton M. Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998, 28:41-47. The importance of revising the criteria for diagnosis and classification of psoriatic arthritis to include dactylitis and enthesopathy is emphasized by these investigators' study of the setting in which dactylitis occurs.
3. 3 Offidani A, Cellini A, Valeri G, Giovagnoni A: Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Dermatol Venereol 1998, 78:463-465. This and several other papers highlight the considerable potential of MR technology to image tendons, cartilage, and inflamed soft tissue that goes far beyond the ability of conventional radiographs. The study reveals several perplexing findings in the joints of patients with psoriasis who lack clinically detectable joint disease, the full significance of which remains to be determined.
4. 4 Barozzi L, Olivieri I, De Matteis M, Padula A, Pavlica P: Seronegative spondyloarthropathies: imaging of spondylitis, enthesitis and dactylitis. Eur J Radiol 1998, 27(suppl 1):12-17.
5. 5 Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J: Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998, 41:58-67.
6. 6 Reiter MF, Boden SD: Inflammatory disorders of the cervical spine. Spine 1998, 23:2755-2766.
7. 7 Jang KA, Sung KJ, Moon KC, Koh JK, Choi JH: Four cases of pustulotic arthro-osteitis. J Dermatol 1998, 25:201-204.
8. 8 Njobvu P, McGill P, Kerr H, Jellis J, Pobee J: SpA and human immunodeficiency virus infection in Zambia. J Rheumatol 1998, 25:1553-1559. A striking relationship between SpA and HIV infection was found in 595 consecutive black Zambians attending an arthritis clinic over a 30-month period in a population in which HIV seroprevalence was 30% among the adults. The prevalence of clinically significant SpA was 12 times greater in HIV-positive than in HIV-negative individuals. ReA, undifferentiated SpA, and psoriatic arthritis were much more common than AS in this population, in which HLA-B27 was not encountered. Moreover, in addition to enhancing susceptibility to this subset of rheumatic diseases, positive HIV status correlated strongly with aggressive and sustained disease.
9. 9 Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G: The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987, 106:19-26.
10. 10 Johnson TM, Duvic M, Rapini RP, Rios A: AIDS exacerbates psoriasis [letter]. N Engl J Med 1985, 313:1415.
11. 11 Duvic M, Johnson TM, Rapini RP, Freeze T, Brewton G, Rios A: Acquired immunodeficiency syndrome associated psoriasis and Reiter's syndrome. Arch Dermatol 1987, 123:1622-1632.
12. 12 Reveille JD, Conant MA, Duvic M: Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rhoum 1990, 33:1574-1578.
13. 13 Kanakoudi-Tsakalidou F, Pardalos G, Pratsidou-Gertsi P, Kansouzidou-Kanakoudi A, Tsangaropoulou-Stinga H: Persistent or severe course of reactive arthritis following Salmonella enteritidis infection: a prospective study of 9 cases. Scand J Rheumatol 1998, 27:431-434.
14. 14 Louthrenoo W, Sukitawut W: A clinical study of Thai patients with spondyloarthropathy. J Med Assoc Thai 1998, 81:986-992.
15. 15 Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG, Setyohadi B, Sudarsono D, et al.: HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol 1997, 24:1111-1114.
16. 16 Lau CS, Burgos-Vargas R, Louthrenoo W, Mok WY, Wordsworth P, Zeng QY: Features of spondyloarthritis around the world. Rheum Dis Clin North Am 1998, 24:753-770.
17. 17 Prieur AM: Spondyloarthropathies in childhood. Baillieres Clin Rheumatol 1998, 12:287-307.
18. 18 Bollow M, Biedermann T, Kannenberg J, Paris S, Schauer-Petrowski C, Minden K, et al.: Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. J Rheumatol 1998, 25:556-564.
19. 19 Boutin RD, Resnick D: The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin [see comments]. AJR Am J Roentgenol 1998, 170:585-591.
20. 20 Sugimoto H, Tamura K, Fujii T: The SAPHO syndrome: defining the radiologic spectrum of diseases comprising the syndrome, Eur Radiol 1998, 8:800-806.
21. 21 Freyschmidt J, Sternberg A: The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol 1998, 8:807-812.
22. 22 Winchester R: The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994, 56:389-466.
23. 23 Khan MA, Kushner I, Braun WE: B27-negative HLA-BW16 in ankylosing spondylitis [letter]. Lancet 1978, 1:1370-1371.
24. 24 Hall PJ, Burman SJ, Laurent MR, Briggs DC, Venning HE, Leak AM, et al.: Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients. Ann Rheum Dis 1986, 45:464-474.
25. 25 Salvarani C, Macchioni P, Cremonesi T, Mantovani W, Battistel B, Rossi F, et al.: The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 1992, 51:73-77.
26. 26 Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC: Identification of self peptides bound to purified HLA-B27. Nature 1991, 353:326-329.
27. 27 Rotzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee HG: Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 1994, 39:74-77.
28. 28 Falk K, Rotzschke O, Takiguchi M, Gnau V, Stevanovic S, Jung G, Rammensee HG: Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 1995, 41:162-164.
29. 29 Boisgerault F, Tieng V, Stolzenberg MC, Dulphy N, Khalil I, Tamouza R, et al.: Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: implications for susceptibility to spondyloarthropathies. J Clin Invest 1996, 98:2764-2770.
30. 30 Sobao Y, Tsuchiya N, Takiguchi M, Tokunaga K: Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondyloarthropathies. Arthritis Rheum 1999, 42:175-181. These investigators elegantly address the question of the molecular basis of a spondylitic disease, using as the starting point the observation that alleles of both the HLA-B27 and HLA-B39 specificities are associated with susceptibility. They identify a subset of peptides that are equivalently bound by both MHC class I molecules.
31. 31 Ridge JP, Di Rosa F, Matzinger P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell [see comments]. Nature 1998, 393:474-478. This paper describes the three-cell interaction of a CD4 T cell with the CD8 T cell in concert with a dendritic cell. This observation causes one to raise the question of whether class I-associated diseases have an accompanying class II association, accounting for the lower penetrance of the class I allele primarily associated with susceptibility. The paper also provides a basis for the possible bypass of the requirement for CD4 T cells in instances of HIV infection of cells in the macrophage-dendritic cell lineage that provides one element in a potential explanation of the cell biologic basis of the association of certain rheumatic diseases, eg, Reiter's syndrome, ReA, psoriatic arthritis, and SpA, with HIV infection.
32. 32 Stuhler G, Schlossman SF: Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc Natl Acad Sci USA 1997, 94:622-627.
33. 33 Costello P, Peterson K, Bresnihan B, Winchester R, Fitzgerald O: Repertoire of synovial fluid CD8+ T cells in psoriatic arthritis appears antigen-driven. Arthritis Rheum 1997, 40(suppl):36.
34. 34 Curran S, Winchester R, Costello P, Peterson K, Sarosy J, Bresnihan B, FitzGerald O: CD8 T cells in psoriatic arthritis synovium appear antigen driven with a non antigen specific CD4 T-cell infiltration. Arthritis Rheum 1998, 41(suppl):346.
35. 35 Gladman DD, Farewell VT, Kopciuk KA, Cook RJ: HLA markers and progression in psoriatic arthritis. J Rheumatol 1998, 25:730-733.